ArticleJournal of Parkinson's disease2014

Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats.

Christopher J Barnum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.